Showing results (11-20 of 21) with videos related to
Sort By:
Pageof 3
Proceedings of the National Academy of Sciences of the United States of America|April 17, 2004
The estrogen-related receptor alpha (ERRalpha) functions in PPARgamma coactivator 1alpha (PGC-1alpha)-induced mitochondrial biogenesisSylvia N Schreiber, Roger Emter, M Benjamin Hock, et al.Genes & Development|January 17, 2008
SCFCdc4 acts antagonistically to the PGC-1alpha transcriptional coactivator by targeting it for ubiquitin-mediated proteolysisBrian L Olson, M Benjamin Hock, Susanna Ekholm-Reed, et al.Bioanalysis|May 7, 2013
Immunogenicity testing strategy and bioanalytical assays for antibody-drug conjugatesSarah A Hoofring, Rocio Lopez, M Benjamin Hock, et al.Birth Defects Research. Part B, Developmental and Reproductive Toxicology|April 23, 2014
Placental transfer of a fully human IgG2 monoclonal antibody in the cynomolgus monkey, rat, and rabbit: a comparative assessment from during organogenesis to late gestationGraeme J Moffat, Marc W Retter, Gayle Kwon, et al.Journal of Clinical Pharmacology|March 14, 2018
Clinical Pharmacokinetics and Pharmacodynamics of Etelcalcetide, a Novel Calcimimetic for Treatment of Secondary Hyperparathyroidism in Patients With Chronic Kidney Disease on HemodialysisBenjamin Wu, Murad Melhem, Raju Subramanian, et al.Clinical Pharmacokinetics|August 13, 2016
Pharmacokinetics, Biotransformation, and Excretion of [<sup>14</sup>C]Etelcalcetide (AMG 416) Following a Single Microtracer Intravenous Dose in Patients with Chronic Kidney Disease on HemodialysisRaju Subramanian, Xiaochun Zhu, M Benjamin Hock, et al.The Journal of Physiology|June 18, 2005
Mitofusins 1/2 and ERRalpha expression are increased in human skeletal muscle after physical exerciseRomain Cartoni, Bertrand Léger, M Benjamin Hock, et al.Neurobiology of Disease|September 15, 2012
Disruption of skeletal muscle mitochondrial network genes and miRNAs in amyotrophic lateral sclerosisAaron P Russell, Shogo Wada, Lodovica Vergani, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|December 14, 2020
Early Phase Clinical Immunogenicity of Valoctocogene Roxaparvovec, an AAV5-Mediated Gene Therapy for Hemophilia ABrian R Long, Philippe Veron, Klaudia Kuranda, et al.Nature Immunology|April 9, 2013
Sterol regulatory element-binding proteins are essential for the metabolic programming of effector T cells and adaptive immunityYoko Kidani, Heidi Elsaesser, M Benjamin Hock, et al.Pageof 3